FDA Investigator Leiyun Boone, PhD

Leiyun Boone, PhD has inspections in 3 countries as of 27 Jul 2023. Leiyun Boone, PhD has collaborated with a combinined 1512 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
5
Last Inspection Date:
27 Jul 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
100002617
Country:
United States of America, Germany, Taiwan
Co-Investigator(s):
Aditi S Thakur, Alberto A Viciedo, Alice C Silva, Amy C Jordan, Amy N Chen, Arie C Menachem, Calvin B Koerner, Caryn M Mcnab, CDR Rochelle B Young, RPh, MSA, Charles Yuanchia Kuo, PhD, Daryl A Dewoskin, Dawn L Wydner, Diane L Raccasi, Dien N Nguyen, Djamila Harouaka, Donald C Obenhuber, PhD, Douglas A Campbell, Dr. Ralph M Bernstein, PhD, Edmund F Mrak, Jr, Guerlain Ulysse, Helen B Ricalde, Jacek Cieslak, PhD, Janet L Bowen, Jennifer M Gogley, Jie He, Jose E Melendez, DDC, Jose M Melendez, Jose O Hernandez, Jose Ohernandez Guzman, Julie D Bringger, Justin A Boyd, Karen A Briggs, Kathleen M Jordan, Kevin D Kallander, Ko U Min, LCDR Debra Emerson, Lei Zhang, PhD, Maan S Abduldayem, Maria Joselopez Barragan, PhD, Mark R Mcclain, Marlene G Swider, Maxwell Van Tassell, PhD, Megan A Haggerty, Michael R Klapal, Michael Shanks, MS, Michelle Y Clark Stuart, Mihaly S Ligmond, Mra Davism, Nailing Zhang, Nealie C Newberger, Patricia Fhughes Troost, Paul L Bellamy, Prabhu P Raju, Qiao Y Bobo, Reyes Candau Chacon, PhD, Richard Ledwidge (nmi), PhD, Robert D Tollefsen, Russell J Glapion, Ruth Moore, PhD, Saleem A Akhtar, Samuel Mindaye, Sangeeta M Khurana, PhD, Sean R Marcsisin, Stacey S Degarmo, Steven Fong, MS, PhD, Steven M Weinman, Susanna E Ford, Analyst, Tamara L Ely, Tamil Arasu, PhD, Thuy T Nguyen, LCDR, Truong Xuan Nguyen (Andy), Wayne E Seifert, Wendy G Tan, PhD, William Hallett, PhD, Yan Wang, Yetao Jin, PhD, Yuan Chia Kuo, Yun Wu, PhD, Yvesna C Blaise, Zhihao Qiu (Peter), PhD, Ziyang Su, PhD

Leiyun Boone, PhD's Documents

Publish Date Document Type Title
July, 2023 FDA 483 ImClone Systems LLC - Form 483, 2023-07-27
June, 2022 FDA 483 EirGenix Inc - Form 483, 2022-06-16
March, 2023 FDA 483 Rentschler Biopharma Inc. - Form 483, 2023-03-22
December, 2021 EIR Immunex Rhode Island Corporation - EIR, 2021-12-07
March, 2023 FDA 483 Rentschler Biopharma SE - Form 483, 2023-03-07
December, 2021 FDA 483 Immunex Rhode Island Corporation - Form 483, 2021-12-07
March, 2023 FDA 483 Rentschler Biopharma Inc. - Form 483, 2023-03-22
December, 2021 FDA 483 Response Immunex Rhode Island Corporation - Form 483R, 2021-12-20

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more